Search results
Investing in Arrowhead Pharmaceuticals (NASDAQ:ARWR) five years ago would have delivered you a 329%...
Simply Wall St. via Yahoo Finance· 1 year agoArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) shareholders might be concerned after seeing the share...
After a year of 4.1% returns, Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR) share price drop last...
Simply Wall St. via Yahoo Finance· 11 months agoKey Insights Significantly high institutional ownership implies Arrowhead Pharmaceuticals' stock...
Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR) Shares Climb 25% But Its Business Is Yet to Catch Up
Simply Wall St. via Yahoo Finance· 1 year agoThose holding Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) shares would be relieved that the share...
A Look At The Intrinsic Value Of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)
Simply Wall St. via Yahoo Finance· 1 year agoToday we'll do a simple run through of a valuation method used to estimate the attractiveness of...
Arrowhead Pharmaceuticals Second Quarter 2023 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 12 months agoArrowhead Pharmaceuticals (NASDAQ:ARWR) Second Quarter 2023 Results Key Financial Results Revenue:...
We Think Arrowhead Pharmaceuticals (NASDAQ:ARWR) Can Easily Afford To Drive Business Growth
Simply Wall St. via Yahoo Finance· 1 year agoWe can readily understand why investors are attracted to unprofitable companies. For example,...
Jobs, housing data, GDP bring investors into December: What to know this week
Yahoo Finance· 1 year agoU.S. investors returning from a holiday weekend will face a deluge of economic data in the week...